Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2464337 Title: Formulation en tablette du N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide pour utilisation pour le traitement de la muscovisidose

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
107084428
WO application number:
US2010024609
Type:
European patent granted for BE
Status:
Open
Publication number:
2464337
WO publication number:
WO2011019413
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
18/02/2010
Grant date:
09/01/2019
EP publication date:
20/06/2012
WO publication date:
17/02/2011
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
09/01/2019
EP B1 publication date:
09/01/2019
EP B2 publication date:
26/06/2024
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
18/02/2030

Applicant

Name:
Vertex Pharmaceuticals Incorporated
Legal Form:
From:
09/01/2019
Address:
50 Northern Avenue, Boston, MA 02210, United States (US)
To:

Agent

1

Name:
KORSTEN Marius
Legal Form:
From:
12/12/2024
Address:
New Babylon City Offices Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)
To:

2

Name:
KORSTEN Marius
Legal Form:
From:
28/03/2019
Address:
Technologiepark 122, 9052, ZWIJNAARDE - GENT, Belgium (BE)
To:
12/12/2024

Inventor

1

Name:
ROWE, William
Legal Form:
Address:
Medford MA 02155, United States (US)

2

Name:
HURTER, Patricia
Legal Form:
Address:
Harvard MA 01451, United States (US)

3

Name:
YOUNG, Christopher, R.
Legal Form:
Address:
Waltham MA 02451, United States (US)

4

Name:
DINEHART, Kirk
Legal Form:
Address:
Holliston MA 01746, United States (US)

5

Name:
VERWIJS, Marinus, Jacobus
Legal Form:
Address:
Framingham MA 01701, United States (US)

6

Name:
OVERHOFF, Kirk
Legal Form:
Address:
Waltham MA 02453, United States (US)

7

Name:
GROOTENHUIS, Peter, D. J.
Legal Form:
Address:
San Diego CA 92130, United States (US)

8

Name:
BOTFIELD, Martyn
Legal Form:
Address:
Concord MA 01742, United States (US)

9

Name:
GROSSI, Alfredo
Legal Form:
Address:
Somerville MA 02145, United States (US)

10

Name:
ZLOKARNIK, Gregor
Legal Form:
Address:
La Jolla CA 92037, United States (US)

11

Name:
VAN GOOR, Fredrick F.
Legal Form:
Address:
San Diego CA 92109, United States (US)

Priority

1

Priority patent number:
583066
Priority date:
13/08/2009
Priority country:
United States (US)

2

Priority patent number:
PCT/US2009/000462
Priority date:
13/08/2009
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
A61K 9/14; A61K 31/47; A61P 19/10; A61P 19/00; A61P 43/00; A61K 45/06; A61K 31/44;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2019/02
Publication date:
04/02/2019
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
EP4
Journal edition number:
2024/12
Publication date:
08/07/2024
Description:
Contains data concerning granted European patents granted and republished in amended form (B2 or B3 publications) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
201902
Publication date:
09/01/2019
Description:
Grant (B1)

2

Issue number:
202426
Publication date:
26/06/2024
Description:
Patent maintained (B2 publication)

Annual fee

Annual fee(s) Due Date:
02/03/2026
Annual fee number:
17
Annual fee amount:
450 Euro
Expected payer:
Last annual fee payment date:
27/02/2025
Last annual fee paid number:
16
Last annual fee paid amount:
400 Euro
Payer:
COMPUTER PACKAGES INC.
Filing date Document type Publication Type Document Description Number of pages File Type
28/03/2019 General Document Declaration of domicile 1 PDF /6/0/6/8/0/0721808606/docs/107084428_0_generaldocument_20190329_081953058.pdf
28/03/2019 Incoming Correspondence (Email) Cover letter 1 PDF /6/0/6/8/0/0721808606/docs/107084428_1_incomingcorrespondenceelectronic_20190329_081954136.pdf
28/03/2019 Outgoing Correspondence 1 PDF /6/0/6/8/0/0721808606/docs/107084428_2_outgoingcorrespondence_20190329_081952289.pdf
12/12/2024 Request For Change Letter and/or Form requesting a change in the Register 1 PDF /6/0/6/8/0/0721808606/docs/107084428_3_rfc_20241217_095354973.pdf
20/12/2024 Outgoing Correspondence Outgoing Correspondence 2 PDF /6/0/6/8/0/0721808606/docs/107084428_4_207902_pie.rfc.per.notif.pdf